GSDMD and endometrial cancer: Additionally, immunohistochemistry (IHC) and protein immunoblotting studies have shown overexpression of NLRP3, caspase-1, and GSDMD in human endometrial cancer tissues and cell lines, with moderate to strong positive staining for these proteins in tumor sections (131, 132).